MADRIGAL PHARMACEUTICA
336.74
26-November-24 16:45:00
15 minutes delayed
Stocks
-8.44
-2.45%
Today's range
329.67 - 347.06
ISIN
N/A
Source
NASDAQ
-
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
27 Nov 2023 16:30:00 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Appoints Ronald Filippo as Chief Information Officer
21 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
15 Nov 2023 16:45:00 By Nasdaq GlobeNewswire
-
10 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Appoints Carole Huntsman as Chief Commercial Officer
10 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial Results
06 Nov 2023 08:00:01 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
02 Nov 2023 16:05:00 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
12 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Pricing of $500 Million Public Offering
28 Sep 2023 22:30:00 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Proposed Public Offering
28 Sep 2023 16:01:00 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
14 Sep 2023 16:30:00 By Nasdaq GlobeNewswire
-
13 Sep 2023 09:10:00 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer
11 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
08 Aug 2023 08:00:01 By Nasdaq GlobeNewswire
-
17 Jul 2023 08:00:01 By Nasdaq GlobeNewswire
-
30 Jun 2023 08:00:00 By Nasdaq GlobeNewswire
-
22 Jun 2023 03:30:00 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Supports International NASH Day on June 8
06 Jun 2023 08:00:02 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
01 Jun 2023 08:00:02 By Nasdaq GlobeNewswire
-
Madrigal Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference
11 May 2023 08:00:02 By Nasdaq GlobeNewswire